MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH
Go back to MetaVia Highlights Peer-Reviewed Publication Supporting the Anti-Fibrotic Potential of Vanoglipel in MASH| (NASDAQ: MTVA) | Delayed: 1.54 -0.03 (1.91%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.57 | 52 Week High | $ | |||
| Open | $1.52 | 52 Week Low | $ | |||
| Day High | $1.64 | P/E | N/A | |||
| Day Low | $1.50 | EPS | $ | |||
| Volume | 517,653 | |||||
